VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
GOTTSCHALK, STEPHEN
One or more keywords matched the following items that are connected to
GOTTSCHALK, STEPHEN
Item Type
Name
Academic Article
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.
Academic Article
HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
Academic Article
T cells redirected to EphA2 for the immunotherapy of glioblastoma.
Academic Article
Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
Concept
Glioblastoma
Academic Article
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
Academic Article
Genetically modified T cells to target glioblastoma.
Academic Article
Cell carriers to attack glioma.
Academic Article
T cells redirected to interleukin-13Ra2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Ra1.
Academic Article
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Ra2-positive Glioma.
Academic Article
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
Academic Article
Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.
Academic Article
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Academic Article
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Ra2-CAR T Cells but Results in Antigen Loss Variants.
Academic Article
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.
Academic Article
CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?
Academic Article
Adoptive Transfer of IL13Ra2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.
Grant
IL13Ra2 targeted T-cell therapy for glioma
Grant
Genetic Approaches to Optimize CAR T cells for Glioblastoma Therapy
Academic Article
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM.
Academic Article
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma.
Search Criteria
Glioblastoma